Condition

HER2-positive, Metastatic Breast Cancer

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions1

Lead sponsors shown2

Clinical trials

2 shown

ARX788 in HER2-positive Metastatic Breast Cancer PatientsNCT06663748 · 2024-11-20

NOT_YET_RECRUITING

ARX788 in HER2-positive Breast Cancer Patients With Brain MetastasesNCT05018702 · 2021-07-14

UNKNOWN

Common interventions

ARX788DRUG2

Leading sponsors

Fudan University1Henan Cancer Hospital1

Trial status mix

NOT_YET_RECRUITING1

UNKNOWN1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.